Eon's Cyclosporine Capsules Receive Approval As First-Time Neoral Generic
Executive Summary
FDA's generic drugs office opened 2000 with the Jan. 13 approval of Eon Labs' cyclosporine softgel capsules as the first generic of Novartis' Neoral capsules, which comprise 96% of the cyclosporine market.
You may also be interested in...
Eon Generic Transdermal Estrogen Patch Under Development With Hexal AG
Eon Labs is developing a generic transdermal estrogen patch with German partner Hexal AG
Eon Generic Transdermal Estrogen Patch Under Development With Hexal AG
Eon Labs is developing a generic transdermal estrogen patch with German partner Hexal AG
Mylan Wins Argument In Exclusivity Case, But Not Terazosin Approval
Mylan will have to wait until after Feb. 9 to launch its generic terazosin capsules even though the company has won a federal court ruling that Geneva's 180-day exclusivity for the product should have already expired.